Capital International Investors
ZNTL icon

Capital International Investors’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Capital International Investors’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-675,371
Closed -$2.76M – 460
2024
Q2 		$2.76M Sell
675,371
-2,144,293
-76% -$23.9M ﹤0.01% 418
2024
Q1 		$44.4M Hold
2,819,664
– – 0.01% 332
2023
Q4 		$42.7M Sell
2,819,664
-308,094
-10% -$4.49M 0.01% 337
2023
Q3 		$62.7M Hold
3,127,758
– – 0.02% 308
2023
Q2 		$88.2M Hold
3,127,758
– – 0.02% 297
2023
Q1 		$53.8M Buy
3,127,758
+79,576
+3% +$1.61M 0.01% 327
2022
Q4 		$61.4M Buy
+3,048,182
New +$65.6M 0.02% 317

Other funds holding ZNTL

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return